Ardeparin: Difference between revisions
m 1 revision imported |
CSV import Tag: Removed redirect |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|An anticoagulant medication}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Ardeparin.png | |||
| image2 = | |||
| width = | |||
| alt = | |||
| caption = Chemical structure of Ardeparin | |||
}} | |||
'''Ardeparin''' is a [[low molecular weight heparin]] (LMWH) used as an [[anticoagulant]] to prevent [[deep vein thrombosis]] (DVT) and other conditions related to excessive [[blood clotting]]. It is derived from [[porcine]] [[heparin]] and is administered via [[subcutaneous injection]]. | |||
==Mechanism of Action== | |||
Ardeparin works by inhibiting the formation of [[fibrin]] clots. It enhances the activity of [[antithrombin III]], which in turn inhibits [[factor Xa]] and [[thrombin]] (factor IIa). This action prevents the conversion of [[fibrinogen]] to fibrin, thereby reducing the formation of clots. | |||
==Clinical Use== | |||
Ardeparin is primarily used for the prevention of DVT, especially in patients undergoing [[orthopedic surgery]] such as [[hip replacement]] or [[knee replacement]]. It is also used in the treatment of [[unstable angina]] and [[myocardial infarction]]. | |||
==Administration== | |||
[[File:Ardeparin.png|Chemical structure of Ardeparin|thumb|right]] | |||
Ardeparin is administered by subcutaneous injection. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to therapy. It is important to monitor the patient's [[platelet count]] and [[renal function]] during treatment. | |||
==Side Effects== | |||
Common side effects of ardeparin include [[bleeding]], [[thrombocytopenia]], and [[allergic reactions]]. Serious bleeding events can occur, especially in patients with other risk factors for bleeding. Monitoring is essential to minimize these risks. | |||
==Contraindications== | |||
Ardeparin is contraindicated in patients with active major bleeding, [[heparin-induced thrombocytopenia]], and hypersensitivity to heparin or pork products. Caution is advised in patients with [[renal impairment]] or a history of [[peptic ulcer disease]]. | |||
==Related Pages== | |||
* [[Heparin]] | |||
* [[Low molecular weight heparin]] | |||
* [[Anticoagulant]] | |||
* [[Deep vein thrombosis]] | |||
* [[Thrombosis]] | |||
[[Category:Anticoagulants]] | |||
[[Category:Heparins]] | |||
Latest revision as of 21:19, 4 March 2025
An anticoagulant medication
| Ardeparin | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Ardeparin is a low molecular weight heparin (LMWH) used as an anticoagulant to prevent deep vein thrombosis (DVT) and other conditions related to excessive blood clotting. It is derived from porcine heparin and is administered via subcutaneous injection.
Mechanism of Action[edit]
Ardeparin works by inhibiting the formation of fibrin clots. It enhances the activity of antithrombin III, which in turn inhibits factor Xa and thrombin (factor IIa). This action prevents the conversion of fibrinogen to fibrin, thereby reducing the formation of clots.
Clinical Use[edit]
Ardeparin is primarily used for the prevention of DVT, especially in patients undergoing orthopedic surgery such as hip replacement or knee replacement. It is also used in the treatment of unstable angina and myocardial infarction.
Administration[edit]
Ardeparin is administered by subcutaneous injection. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to therapy. It is important to monitor the patient's platelet count and renal function during treatment.
Side Effects[edit]
Common side effects of ardeparin include bleeding, thrombocytopenia, and allergic reactions. Serious bleeding events can occur, especially in patients with other risk factors for bleeding. Monitoring is essential to minimize these risks.
Contraindications[edit]
Ardeparin is contraindicated in patients with active major bleeding, heparin-induced thrombocytopenia, and hypersensitivity to heparin or pork products. Caution is advised in patients with renal impairment or a history of peptic ulcer disease.
